Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Prepaid Assets (2020 - 2025)

Genenta Science S.p.A (GNTA) posted Prepaid Assets of $2.1 million for Q4 2025, down 43.42% sequentially from $3.8 million in Q2 2025, and up 9.96% YoY from $1.9 million in Q4 2024.

Genenta Science S.p.A (GNTA) Prepaid Assets (2020 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Prepaid Assets for 6 years, with the latest figure at $2.1 million in Q4 2025.

  • Quarterly Prepaid Assets rose 9.96% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 9.96% YoY) and the FY2025 annual result came in at $2.1 million, up 9.96% from the prior year.
  • Prepaid Assets declined to $2.1 million in Q4 2025 per GNTA's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $3.8 million in Q2 2025 and troughed at $217784.9 in Q2 2023.
  • A 5-year average of $2.1 million and a median of $2.0 million in 2022 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets tumbled 92.54% in 2023, then surged 722.46% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.7 million in 2021, then advanced by 13.11% to $2.0 million in 2022, then surged by 35.79% to $2.7 million in 2023, then decreased by 27.4% to $1.9 million in 2024, then rose by 9.96% to $2.1 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $2.1 million, $3.8 million, and $1.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.13 Mn
Jun 30, 2025 3.77 Mn
Dec 31, 2024 1.94 Mn
Jun 30, 2024 1.79 Mn
Dec 31, 2023 2.67 Mn
Jun 30, 2023 217,784.88
Dec 31, 2022 1.97 Mn
Jun 30, 2022 2.92 Mn
Dec 31, 2021 1.74 Mn
Dec 31, 2020 1.13 Mn